RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 127 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,684,034 | +46.7% | 73,459 | +5.5% | 0.00% | +100.0% |
| Q2 2023 | $1,147,671 | +74.9% | 69,598 | +22.2% | 0.00% | 0.0% |
| Q1 2022 | $656,000 | +8.6% | 56,942 | -5.9% | 0.00% | 0.0% |
| Q4 2021 | $604,000 | -24.5% | 60,537 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $800,000 | -33.1% | 61,287 | +0.5% | 0.00% | -50.0% |
| Q2 2021 | $1,195,000 | +39.9% | 61,012 | +51.9% | 0.00% | +100.0% |
| Q1 2021 | $854,000 | -30.9% | 40,155 | -3.4% | 0.00% | -50.0% |
| Q4 2020 | $1,236,000 | +47.3% | 41,578 | +7.4% | 0.00% | +100.0% |
| Q3 2020 | $839,000 | -15.7% | 38,713 | -13.3% | 0.00% | -50.0% |
| Q2 2020 | $995,000 | +89.5% | 44,628 | +29.3% | 0.00% | +100.0% |
| Q1 2020 | $525,000 | -29.4% | 34,504 | +6.5% | 0.00% | 0.0% |
| Q4 2019 | $744,000 | +33.3% | 32,395 | +25.3% | 0.00% | 0.0% |
| Q3 2019 | $558,000 | -2.8% | 25,853 | -0.9% | 0.00% | 0.0% |
| Q2 2019 | $574,000 | +6.9% | 26,093 | +33.1% | 0.00% | 0.0% |
| Q1 2019 | $537,000 | +2.1% | 19,603 | +0.3% | 0.00% | 0.0% |
| Q4 2018 | $526,000 | +49.0% | 19,553 | +61.7% | 0.00% | 0.0% |
| Q3 2018 | $353,000 | -1.1% | 12,095 | +5.8% | 0.00% | 0.0% |
| Q2 2018 | $357,000 | – | 11,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |